LHTC.DE vs. PPH
LHTC.DE (Lyxor STOXX Europe 600 Healthcare UCITS ETF Acc) and PPH (VanEck Vectors Pharmaceutical ETF) are both Health & Biotech Equities funds - LHTC.DE tracks the STOXX® Europe 600 Health Care while PPH tracks the MVIS US Listed Pharmaceutical 25 Index. Both are passively managed. Over the past 10 years, LHTC.DE returned 5.88%/yr vs 7.73%/yr for PPH. At a 0.49 correlation, their price movements are largely independent. LHTC.DE charges 0.30%/yr vs 0.36%/yr for PPH.
Performance
LHTC.DE vs. PPH - Performance Comparison
Loading charts...
Different Trading Currencies
LHTC.DE is traded in EUR, while PPH is traded in USD. To make them comparable, the PPH values have been converted to EUR using the latest available exchange rates.
Returns By Period
In the year-to-date period, LHTC.DE achieves a -2.55% return, which is significantly lower than PPH's 5.37% return. Over the past 10 years, LHTC.DE has underperformed PPH with an annualized return of 5.88%, while PPH has yielded a comparatively higher 7.73% annualized return.
LHTC.DE
- 1D
- 3.03%
- 1M
- 0.27%
- YTD
- -2.55%
- 6M
- -1.03%
- 1Y
- 4.57%
- 3Y*
- 2.35%
- 5Y*
- 5.04%
- 10Y*
- 5.88%
PPH
- 1D
- 1.50%
- 1M
- 5.49%
- YTD
- 5.37%
- 6M
- 8.48%
- 1Y
- 21.51%
- 3Y*
- 10.67%
- 5Y*
- 11.31%
- 10Y*
- 7.73%
LHTC.DE vs. PPH - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
LHTC.DE Lyxor STOXX Europe 600 Healthcare UCITS ETF Acc | -2.55% | 7.11% | 3.92% | 7.59% | -6.20% | 25.48% | -1.95% | 27.54% | 2.95% | 4.36% |
PPH VanEck Vectors Pharmaceutical ETF | 5.37% | 7.52% | 15.18% | 3.74% | 9.00% | 26.61% | -3.21% | 22.09% | -1.47% | 1.07% |
Correlation
The correlation between LHTC.DE and PPH is 0.60, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.60 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.57 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.56 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.55 |
Correlation (All Time) Calculated using the full available price history since Aug 29, 2007 | 0.49 |
The correlation between LHTC.DE and PPH shifts across timeframes, from 0.49 (all time) to 0.60 (1 year), reflecting how their relationship changes across market environments.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
LHTC.DE vs. PPH — Risk / Return Rank
LHTC.DE
PPH
LHTC.DE vs. PPH - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Lyxor STOXX Europe 600 Healthcare UCITS ETF Acc (LHTC.DE) and VanEck Vectors Pharmaceutical ETF (PPH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| LHTC.DE | PPH | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.96 | ||
| Sortino ratioReturn per unit of downside risk | -1.41 | ||
| Omega ratioGain probability vs. loss probability | 1.07 | 1.23 | -0.16 |
| Calmar ratioReturn relative to maximum drawdown | 0.40 | 2.16 | -1.75 |
| Martin ratioReturn relative to average drawdown | 0.89 | 4.97 | -4.09 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| LHTC.DE | PPH | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.30 | 1.26 | -0.96 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.32 | 0.75 | -0.42 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.38 | 0.44 | -0.06 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.44 | 0.53 | -0.09 |
Drawdowns
LHTC.DE vs. PPH - Drawdown Comparison
The maximum LHTC.DE drawdown since its inception was -40.53%, which is greater than PPH's maximum drawdown of -31.54%. Use the drawdown chart below to compare losses from any high point for LHTC.DE and PPH.
Loading charts...
Drawdown Indicators
| LHTC.DE | PPH | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -40.53% | -31.54% | -8.99% |
Max Drawdown (1Y)Largest decline over 1 year | -12.43% | -10.02% | -2.41% |
Max Drawdown (3Y)Largest decline over 3 years | -26.48% | -20.54% | -5.94% |
Max Drawdown (5Y)Largest decline over 5 years | -26.48% | -20.54% | -5.94% |
Max Drawdown (10Y)Largest decline over 10 years | -26.48% | -28.74% | +2.26% |
Current DrawdownCurrent decline from peak | -11.60% | -2.05% | -9.55% |
Average DrawdownAverage peak-to-trough decline | -9.31% | -9.92% | +0.61% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 5.67% | 4.34% | +1.33% |
Volatility
LHTC.DE vs. PPH - Volatility Comparison
The current volatility for Lyxor STOXX Europe 600 Healthcare UCITS ETF Acc (LHTC.DE) is 5.69%, while VanEck Vectors Pharmaceutical ETF (PPH) has a volatility of 6.11%. This indicates that LHTC.DE experiences smaller price fluctuations and is considered to be less risky than PPH based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| LHTC.DE | PPH | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 5.69% | 6.11% | -0.42% |
Volatility (6M)Calculated over the trailing 6-month period | 11.67% | 12.03% | -0.36% |
Volatility (1Y)Calculated over the trailing 1-year period | 16.60% | 17.13% | -0.53% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 15.44% | 15.19% | +0.25% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 15.57% | 17.46% | -1.89% |
LHTC.DE vs. PPH - Expense Ratio Comparison
LHTC.DE has a 0.30% expense ratio, which is lower than PPH's 0.36% expense ratio.
Dividends
LHTC.DE vs. PPH - Dividend Comparison
LHTC.DE has not paid dividends to shareholders, while PPH's dividend yield for the trailing twelve months is around 2.04%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
LHTC.DE Lyxor STOXX Europe 600 Healthcare UCITS ETF Acc | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
PPH VanEck Vectors Pharmaceutical ETF | 2.04% | 1.78% | 1.98% | 2.09% | 1.55% | 1.62% | 1.66% | 1.77% | 1.97% | 1.92% | 2.43% | 1.93% |
Frequently Asked Questions
LHTC.DE and PPH have a correlation of 0.60, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, LHTC.DE is cheaper at 0.30% per year. The better choice depends on whether you care most about return, fees, risk, or income.
LHTC.DE is cheaper with a 0.30% expense ratio, compared with 0.36% for PPH.
LHTC.DE tracks STOXX® Europe 600 Health Care, while PPH tracks MVIS US Listed Pharmaceutical 25 Index. They also come from different issuers: Amundi and VanEck. Their fees differ too: 0.30% for LHTC.DE and 0.36% for PPH.
Find the right allocation for LHTC.DE and PPH
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer